BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16554168)

  • 1. Synthesis and preliminary biological evaluation of [123I]Me2Pyr, a new potential ligand for imaging of central cannabinoid CB1 receptors.
    Gielow P; Klinge P; Knapp WH; Berding G
    Appl Radiat Isot; 2006 Jul; 64(7):763-8. PubMed ID: 16554168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.
    Donohue SR; Varnäs K; Jia Z; Gulyás B; Pike VW; Halldin C
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6209-12. PubMed ID: 19767206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of [O-methyl-11C]1-(2-chlorophenyl)-5-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide: a potential PET ligand for CB1 receptors.
    Kumar JS; Prabhakaran J; Arango V; Parsey RV; Underwood MD; Simpson NR; Kassir SA; Majo VJ; Van Heertum RL; Mann JJ
    Bioorg Med Chem Lett; 2004 May; 14(10):2393-6. PubMed ID: 15109619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
    Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
    J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.
    Tobiishi S; Sasada T; Nojiri Y; Yamamoto F; Mukai T; Ishiwata K; Maeda M
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1213-7. PubMed ID: 17666847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.
    Gatley SJ; Gifford AN; Volkow ND; Lan R; Makriyannis A
    Eur J Pharmacol; 1996 Jul; 307(3):331-8. PubMed ID: 8836622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new high-yield synthetic route to PET CB1 radioligands [11C]OMAR and its analogs.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3704-9. PubMed ID: 22542014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
    Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA
    Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosynthesis and biodistribution in mice of a 18F-labeled analog of O-1302 for use in cerebral CB1 cannabinoid receptor imaging.
    Nojiri Y; Ishiwata K; Qinggeletu ; Tobiishi S; Sasada T; Yamamoto F; Mukai T; Maeda M
    Biol Pharm Bull; 2008 Jun; 31(6):1274-8. PubMed ID: 18520068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand.
    Lan R; Gatley J; Lu Q; Fan P; Fernando SR; Volkow ND; Pertwee R; Makriyannis A
    AAPS PharmSci; 1999; 1(2):E4. PubMed ID: 11741201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds.
    Li Z; Gifford A; Liu Q; Thotapally R; Ding YS; Makriyannis A; Gatley SJ
    Nucl Med Biol; 2005 May; 32(4):361-6. PubMed ID: 15878505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
    Fulp A; Zhang Y; Bortoff K; Seltzman H; Snyder R; Wiethe R; Amato G; Maitra R
    Bioorg Med Chem; 2016 Mar; 24(5):1063-70. PubMed ID: 26827137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: potent, orally-active 1,4-disubstituted imidazoles.
    Dow RL; Hadcock JR; Scott DO; Schneider SR; Paight ES; Iredale PA; Carpino PA; Griffith DA; Hammond M; Dasilva-Jardine P
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5351-4. PubMed ID: 19683918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo.
    Gatley SJ; Lan R; Volkow ND; Pappas N; King P; Wong CT; Gifford AN; Pyatt B; Dewey SL; Makriyannis A
    J Neurochem; 1998 Jan; 70(1):417-23. PubMed ID: 9422389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model.
    Srivastava BK; Joharapurkar A; Raval S; Patel JZ; Soni R; Raval P; Gite A; Goswami A; Sadhwani N; Gandhi N; Patel H; Mishra B; Solanki M; Pandey B; Jain MR; Patel PR
    J Med Chem; 2007 Nov; 50(24):5951-66. PubMed ID: 17979261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
    Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
    Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.
    Kumar Srivastava B; Soni R; Patel JZ; Jha S; Shedage SA; Gandhi N; Sairam KV; Pawar V; Sadhwani N; Mitra P; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3882-6. PubMed ID: 18585913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors.
    Benedetti F; Amanzio M; Rosato R; Blanchard C
    Nat Med; 2011 Oct; 17(10):1228-30. PubMed ID: 21963514
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.